MAZE

Maze Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$28.71

Market Cap

$1.43B

Beta

4.47

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-100.00%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-7.90%

Debt / Equity0.07

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for MAZE.